VanEck Vectors® Biotech ETF
BBH NASDAQ
VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marke...
Hover to inspectDrag to measure a move← → to step through days
- Fund size
- 334M as of Feb 2020
- Expense ratio
- 0.35% per year
- Dividend yield
- 0.40% Yearly
- Volatility · 1Y
- 21.8% Above Average
- Beta
- 0.67 vs the market
- 52-week range
- 172.63245.64
How BBH has paid off
Price return over every period, and total return with dividends reinvested, set against its benchmark.
Return by period
Price · to Oct 12Total return vs benchmark
Total Market US Cap Weighted 1200 IndexOver 1 year, BBH returned +39.1% with dividends reinvested — −14.6 pts behind its benchmark.
How bumpy is the ride?
Return only means something next to the risk taken to earn it. Volatility, drawdowns and market sensitivity over 1 year.
Volatility
Annualized · 1YA typical year sees the price swing about ±22% around its trend.
Drawdown from peak
How far below its previous high the price has been Deepest fall −10.5% on May 18, 2026 — 111 days after the previous high
More than 5% below a high 30% of the time.
Risk vs reward
1YOver 1 year, BBH delivered less return with more risk than its benchmark.
Market sensitivity
BetaA beta of 0.67 means BBH has moved less than the market.
Trend & momentum
Where the price sits against its moving averages, and how stretched the recent move is.
Price vs moving averages
Uptrend- 12-day average238.94 +0.1%
- 26-day average237.40 +0.8%
- 50-day average231.52 +3.3%
- 200-day average206.39 +15.9%
The price is above 4 of 4 averages. The 50-day average is above the 200-day, a sign of a rising longer-term trend.
Relative strength (RSI)
NeutralRSI compares recent gains with recent losses on a 0–100 scale. Above 70 a move is often considered stretched, below 30 washed out.
Technical indicators describe past prices. They are not a forecast.
Inside the fund
Health Care · Biotech — tracking the MVIS® US Listed Biotech 25 Index.
- Assets under management334MUSD
- Expense ratio0.35%per year
- Holdings25
- Risk score5.8Medium
Launched December 2011. Listed options available. Fund data as of Feb 28, 2020.
What it pays you
Cash distributions over the last twelve months, and how they have grown.
About 4 USD a year for every 1,000 USD invested at today's price.
- Per share
- 0.96
- Frequency
- Yearly
- Last paid
- Dec 22, 2025
Last 12 months
0.96 USD / shareWhere BBH shows up
Curated themes and indices that hold BBH. Open one to see it in context, or test the whole theme in a portfolio.
About VanEck Vectors® Biotech ETF
VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
- Featured in 1 curated theme
- 25 holdings
- Ticker
- BBH
- Exchange
- NASDAQ
- ISIN
- US92189F7261
- CUSIP
- 92189F726
- Currency
- U.S. Dollar (USD)
- Country
- USA
- Sector
- Health Care
- Industry
- Biotech
- Benchmark
- Total Market US Cap Weighted 1200 Index
All key statistics
Details
Shareas of Oct 12, 2026
Dataas of Feb 28, 2020
Put BBH to the test
See how it would change the return and the risk of a portfolio, with virtual money, before a single real dollar moves.
Data for information only, not investment advice. Past performance does not guarantee future results.